These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 19446747)

  • 21. Fluorescence in situ hybridization analysis of 110 hematopoietic disorders with chromosome 5 abnormalities: do de novo and therapy-related myelodysplastic syndrome-acute myeloid leukemia actually differ?
    Lessard M; Hélias C; Struski S; Perrusson N; Uettwiller F; Mozziconacci MJ; Lafage-Pochitaloff M; Dastugue N; Terré C; Brizard F; Cornillet-Lefebvre P; Mugneret F; Barin C; Herry A; Luquet I; Desangles F; Michaux L; Verellen-Dumoulin C; Perrot C; Van den Akker J; Lespinasse J; Eclache V; Berger R;
    Cancer Genet Cytogenet; 2007 Jul; 176(1):1-21. PubMed ID: 17574959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A case of atypical myelodysplastic syndrome with micromegakaryocytes, normal platelet count, and t(3;12)(q21;p13) with inv(3)(q21q26).
    Schnittger S; Schoch C; Streubel B; Hinrichs HF; Otremba B; Parwaresch R; Fonatsch C
    Genes Chromosomes Cancer; 1997 Nov; 20(3):292-8. PubMed ID: 9365837
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Constitutional t(5;7)(q11;p15) rearranged to acquire monosomy 7q and trisomy 1q in a patient with myelodysplastic syndrome transforming to acute myelocytic leukemia.
    Ganly P; McDonald M; Spearing R; Morris CM
    Cancer Genet Cytogenet; 2004 Mar; 149(2):125-30. PubMed ID: 15036888
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A novel translocation t(1;18)(p31;p11) in a patient with myelodysplastic syndrome].
    Du B; Wu YF; Pan JL; Xue YQ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Feb; 22(1):74-5. PubMed ID: 15696486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Multiplex fluorescence in situ hybridization in detecting complex chromosomal aberrations in myelodysplastic syndromes].
    Xiao B; Li JY; Pan JL; Ma L; Qiu HR; Wu YF; Xue YQ
    Zhonghua Xue Ye Xue Za Zhi; 2005 Sep; 26(9):513-6. PubMed ID: 16468325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chromosome 5q deletion and epigenetic suppression of the gene encoding alpha-catenin (CTNNA1) in myeloid cell transformation.
    Liu TX; Becker MW; Jelinek J; Wu WS; Deng M; Mikhalkevich N; Hsu K; Bloomfield CD; Stone RM; DeAngelo DJ; Galinsky IA; Issa JP; Clarke MF; Look AT
    Nat Med; 2007 Jan; 13(1):78-83. PubMed ID: 17159988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Several chromosomes involved in translocations with chromosome 5 shown with fluorescence in situ hybridization in patients with malignant myeloid disorders.
    Bram S; Rödjer S; Swolin B
    Cancer Genet Cytogenet; 2004 Nov; 155(1):74-8. PubMed ID: 15527906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Morphologic analysis in myelodysplastic syndromes with del(5q) treated with lenalidomide. A Japanese multiinstitutional study.
    Matsuda A; Taniwaki M; Jinnai I; Harada H; Watanabe M; Suzuki K; Yanagita S; Suzuki T; Yoshida Y; Kimura A; Tsudo M; Tohyama K; Takatoku M; Ozawa K
    Leuk Res; 2012 May; 36(5):575-80. PubMed ID: 22172461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 5q- myelodysplastic syndromes: chromosome 5q genes direct a tumor-suppression network sensing actin dynamics.
    Eisenmann KM; Dykema KJ; Matheson SF; Kent NF; DeWard AD; West RA; Tibes R; Furge KA; Alberts AS
    Oncogene; 2009 Oct; 28(39):3429-41. PubMed ID: 19597464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Derivative (1)t(1;16)(p11;p11.1) in myelodysplastic syndrome: a case report and review of the literature.
    Lunghi M; Casorzo L; De Paoli L; Riccomagno P; Rossi D; Gaidano G
    Cancer Genet Cytogenet; 2010 Jan; 196(1):89-92. PubMed ID: 19963141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical, morphological, cytogenetic, and prognostic features of patients with myelodysplastic syndromes and del(5q) including band q31.
    Giagounidis AA; Germing U; Haase S; Hildebrandt B; Schlegelberger B; Schoch C; Wilkens L; Heinsch M; Willems H; Aivado M; Aul C
    Leukemia; 2004 Jan; 18(1):113-9. PubMed ID: 14586479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myelodysplastic syndromes with del(5q): indications and strategies for cytogenetic testing.
    Haferlach C; Bacher U; Tiu R; Maciejewski JP; List A
    Cancer Genet Cytogenet; 2008 Dec; 187(2):101-11. PubMed ID: 19027491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deletions of PURA, at 5q31, and PURB, at 7p13, in myelodysplastic syndrome and progression to acute myelogenous leukemia.
    Lezon-Geyda K; Najfeld V; Johnson EM
    Leukemia; 2001 Jun; 15(6):954-62. PubMed ID: 11417483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone marrow morphology in myelodysplastic syndrome associated with isolated del(5q).
    Naresh KN; Reid A
    Am J Hematol; 2010 Aug; 85(8):609-10. PubMed ID: 20658591
    [No Abstract]   [Full Text] [Related]  

  • 35. Three rearrangements of chromosome 5 in a patient with myelodysplastic syndrome: an atypical deletion 5q, a complex intrachromosomal rearrangement of chromosome 5, and a paracentric inversion of chromosome 5.
    Douet-Guilbert N; Basinko A; Eveillard JR; Morel F; Le Bris MJ; Guéganic N; Bovo C; Herry A; Berthou C; De Braekeleer M
    Cancer Genet Cytogenet; 2010 Dec; 203(2):303-8. PubMed ID: 21156249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isochromosome of a deleted 20q: a rare but recurrent chromosome abnormality in myelodysplastic syndromes.
    Saunders K; Czepulkowski B; Sivalingam R; Hayes JP; Aldouri M; Sekhar M; Cummins M; Ho A; Mufti GJ
    Cancer Genet Cytogenet; 2005 Jan; 156(2):154-7. PubMed ID: 15642396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of conventional cytogenetics and FISH for EGR1 to detect deletion 5q in hematological disorders and to assess response to treatment with Lenalidomide.
    Zou YS; Fink SR; Stockero KJ; Paternoster SF; Smoley SA; Tun HW; Reeder CB; Tefferi A; Dewald GW
    Leuk Res; 2007 Sep; 31(9):1185-9. PubMed ID: 17125835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of the chromosomal region 5q11-q31 in the myeloid cell line HL-60: characterization by comparative genomic hybridization and fluorescence in situ hybridization.
    Shipley J; Weber-Hall S; Birdsall S
    Genes Chromosomes Cancer; 1996 Mar; 15(3):182-6. PubMed ID: 8721684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A case of myelodysplastic syndrome with erythroid hypoplasia associated with a familial translocation t(3;14)(p21.1;q24.1).
    Dinçol G; Oztürk S; Palanduz S; Tutkan G; Yildirim N; Ayer M; Güvenç S
    Am J Hematol; 2006 Nov; 81(11):883-7. PubMed ID: 16888788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myelodysplastic syndrome in a patient with a unique constitutional chromosome abnormality t(2;11) (q31;p13).
    Hinoda Y; Itoh H; Takahashi T; Adachi M; Tsujisaki M; Imai K; Yachi A
    Int J Hematol; 1992 Aug; 56(1):95-7. PubMed ID: 1391810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.